UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands |
1 Months Ended | 2 Months Ended | 3 Months Ended | 4 Months Ended | 6 Months Ended |
|---|---|---|---|---|---|
Jun. 11, 2021 |
Jul. 31, 2021 |
Jul. 31, 2022 |
Jun. 11, 2021 |
Jul. 31, 2022 |
|
| Revenues: | |||||
| Total revenues | $ 34,814 | $ 75,466 | $ 140,574 | $ 102,494 | $ 275,413 |
| Operating expenses: | |||||
| Costs of revenues | 6,949 | 22,290 | 34,998 | 22,043 | 73,008 |
| Content and software development | 4,510 | 6,208 | 19,693 | 15,012 | 36,026 |
| Selling and marketing | 10,905 | 19,650 | 41,848 | 34,401 | 81,410 |
| General and administrative | 4,652 | 16,824 | 26,367 | 16,471 | 55,711 |
| Amortization of intangible assets | 14,575 | 18,493 | 45,200 | 46,492 | 84,758 |
| Impairment of goodwill and intangible assets | 70,475 | 70,475 | |||
| Recapitalization and acquisition-related costs | 4,927 | 9,900 | 8,452 | 6,641 | 21,764 |
| Restructuring | (910) | 287 | 4,323 | (576) | 8,279 |
| Total operating expenses | 45,608 | 93,652 | 251,356 | 140,484 | 431,431 |
| Operating loss | (10,794) | (18,186) | (110,782) | (37,990) | (156,018) |
| Other income (expense), net | 304 | (992) | 80 | (167) | 1,132 |
| Fair value adjustment of warrants | 800 | 17,115 | 6,846 | 900 | 16,952 |
| Fair value adjustment of hedge instruments | (15,065) | (15,065) | |||
| Interest income | 53 | 9 | 10 | 60 | 170 |
| Interest expense | (5,354) | (9,265) | (11,470) | (16,763) | (23,007) |
| Loss before benefit from income taxes | (14,991) | (11,319) | (130,381) | (53,960) | (175,836) |
| Benefit from income taxes | (464) | (1,996) | (3,065) | (3,521) | (25,402) |
| Loss from continuing operations | (14,527) | (9,323) | (127,316) | (50,439) | (150,434) |
| Income (loss) from discontinued operations, net of tax | 2,668 | (2,531) | 5,817 | 1,175 | 7,292 |
| Net loss | $ (11,859) | $ (11,854) | $ (121,499) | $ (49,264) | $ (143,142) |
| Gain (loss) per share: | |||||
| Basic - continuing operations | $ (3.63) | $ (0.07) | $ (0.78) | $ (12.61) | $ (0.98) |
| Basic - discontinued operations | 0.67 | (0.02) | 0.04 | 0.29 | 0.05 |
| Basic | (2.96) | (0.09) | (0.74) | (12.32) | (0.93) |
| Diluted - continuing operations | (3.63) | (0.07) | (0.78) | (12.61) | (0.98) |
| Diluted - discontinued operations | 0.67 | (0.02) | 0.04 | 0.29 | 0.05 |
| Diluted | $ (2.96) | $ (0.09) | $ (0.74) | $ (12.32) | $ (0.93) |
| Weighted average common share outstanding: | |||||
| Basic | 4,000 | 133,059 | 164,089 | 4,000 | 153,442 |
| Diluted | 4,000 | 133,059 | 164,089 | 4,000 | 153,442 |
| X | ||||||||||
- Definition Amount of recapitalization and transaction-related costs incurred during the period. No definition available.
|
| X | ||||||||||
- Definition The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate cost of goods produced and sold and services rendered during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Total costs of sales and operating expenses for the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of expense (income) related to adjustment to fair value of warrant liability. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Gain (loss) incurred in hedging activities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill. No definition available.
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The net amount of operating interest income (expense). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of income (expense) related to nonoperating activities, classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The aggregate total amount of expenses directly related to the marketing or selling of products or services. No definition available.
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|